
Nureca Ltd is Rated Sell by MarketsMOJO
2026-11-11 10:11:20Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 26 October 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 11 November 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trend, and technical outlook.
Read More
Nureca Ltd Valuation Shifts to Fair Amidst Challenging Market Performance
2026-11-05 08:03:25Nureca Ltd, a micro-cap player in the Healthcare Services sector, has recently undergone a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite this adjustment, the company’s price-to-earnings (P/E) ratio remains elevated at 61.7 times, signalling continued premium pricing relative to earnings. This article analyses the implications of these valuation changes in the context of Nureca’s financial metrics, peer comparisons, and market performance.
Read MoreNureca Ltd Falls 6.77%: Downgrade and Valuation Shift Mark a Challenging Week
2026-10-31 12:02:59Key Events This Week 26 Oct: Stock drops 3.53% following downgrade to Sell 27 Oct: Mojo Grade officially downgraded to Sell amid mixed financials 29 Oct: Valuation grade shifts from expensive to fair despite price decline 30 Oct: Week closes at Rs.298.80, down 1.71% on the day Week OpenRs.320.50 Week Close<div class="...
Read More
Nureca Ltd Valuation Shifts to Fair Amidst Challenging Market Performance
2026-10-29 08:01:46Nureca Ltd, a micro-cap player in the Healthcare Services sector, has seen a notable shift in its valuation parameters, moving from an expensive to a fair valuation grade. Despite a recent downgrade in its Mojo Grade from Hold to Sell, the company’s price-to-earnings (P/E) and price-to-book value (P/BV) ratios suggest a more balanced price attractiveness relative to its historical levels and peer group. This article analyses the valuation changes, financial metrics, and market performance to provide a comprehensive view for investors.
Read More
Nureca Ltd Downgraded to Sell Amid Mixed Financials and Technical Signals
2026-10-27 08:51:46Nureca Ltd, a micro-cap player in the healthcare services sector, has seen its investment rating downgraded from Hold to Sell as of 26 October 2026. This shift reflects a complex interplay of deteriorating technical indicators, weak long-term financial fundamentals, and valuation concerns despite recent positive quarterly results and rising promoter confidence.
Read MoreNureca Ltd Falls 2.14%: 4 Key Events Shaping This Week’s Volatility
2026-10-24 12:02:24Key Events This Week 19 Oct: Stock opens at Rs.317.90, down 2.93% 21 Oct: Hits upper circuit at Rs.328.90 (+5.0%) amid strong buying 22 Oct: Upper circuit again at Rs.337.85 (+3.37%) and rating upgraded to Hold 23 Oct: Shares plunge to lower circuit at Rs.316.70 (-4.99%) on heavy selling Week OpenRs.327.50 Week Close<...
Read More
Nureca Ltd Locks at Lower Circuit With 5% Loss — Sellers Queue, No Buyers in Sight
2026-10-23 12:00:18At Rs 316.7, sellers were still queuing — but there were no buyers willing to take the other side. Nureca Ltd locked at its lower circuit of 5% on 23 Oct 2026, with unfilled sell orders and a frozen price.
Read More
Nureca Ltd Upgraded to Hold as Technicals Improve and Financials Show Positive Momentum
2026-10-22 08:45:01Nureca Ltd, a micro-cap player in the healthcare services sector, has seen its investment rating upgraded from Sell to Hold, reflecting improved technical indicators and positive quarterly financial results. The revised MarketsMOJO Mojo Score now stands at 51.0, signalling a cautious but optimistic outlook amid mixed fundamental signals and rising promoter confidence.
Read More
Nureca Ltd is Rated Sell by MarketsMOJO
2026-10-19 10:11:04Nureca Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 Oct 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 19 October 2026, providing investors with an up-to-date perspective on the company’s fundamentals, valuation, financial trends, and technical outlook.
Read MoreDisclosure Under Regulation 7(2) Of Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015 (PIT Regulations)
12-Nov-2026 | Source : BSEDisclosure under Regulation 7(2) of Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations 2015 ("PIT Regulations")
Announcement under Regulation 30 (LODR)-Credit Rating
03-Nov-2026 | Source : BSEIntimation about Credit Rating
Announcement under Regulation 30 (LODR)-Newspaper Publication
22-Oct-2026 | Source : BSECopy of Newspaper Publication
Corporate Actions
No Upcoming Board Meetings
Nureca Ltd has declared 30% dividend, ex-date: 24 Feb 22
No Splits history available
No Bonus history available
No Rights history available